In conclusion, our results demonstrated that miR-34a expression was significantly correlated with lymph node metastasis and prognosis of TSCC patients and could inhibit migration and invasion of TSCC cell lines via targeting MMP9 and MMP14. This evidence concerns the gene MMP9 and metastatic malignant neoplasm in the lymph nodes.